DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the 2010 Q4 release of its DATATRAK eClinical™ solution. Leading the enhancements in this release is the new Cross-Trial Reporting functionality that increases visibility of performance metrics across studies. In addition, advancements to the Local Laboratory Data component will improve trial efficiencies surrounding range and export management. For more information on these and the other new features including the new freeze functionality for data cleaning, please click here to visit our website.
"Each release reinforces DATATRAK's commitment to our clients – delivering eClinical excellence through the development of new products and system enhancements that address the needs of our complex industry. The Company has consistently invested in Research & Development to ensure our market leadership in unified, end-to-end eClinical solutions," said Chris Wilke, DATATRAK's Chief Technology Officer. "This release safely accelerates DATATRAK's customers forward in the CTMS arena with our advanced cross-trial reporting functionality, a new level of efficiency in the cleaning and locking of data, and many other features our customers have requested."
DATATRAK eClinical™ is a unified, end-to-end clinical trial solution. By implementing a flexible, permission-based platform, DATATRAK is able to layer modules that support the clinical trial process, from planning to submission as well as integrate with third-party data sources. This unified technology provides one database, one interface and one point of access to all clinical trial activities.
Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers